CLINICAL_TRIALS
trial_result
· 2019-10-22
Clinical Trial Update: Effect of Tolvaptan on Mid- to Long-term Prognosis of Heart Failure Patients [Phase 4]
Summary
Phase 4 clinical trial evaluating the effect of tolvaptan on mid- to long-term prognosis in heart failure patients has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Otsuka Pharmaceutical Co., Ltd. | Conditions: Heart Failure | Phase 4 | Status: COMPLETED | Results posted: 2019-10-22